secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0000950170-24-004821
Event type: regulatory
Sentiment:  positive
Materiality: 0.68
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix announces LCD open meeting for kidneyIntelX.dkd; potential coverage for 5M more Medicare patients
--------------------------------------------------------------------------------

- NGS LCD Open Meeting scheduled for February 29, 2024 to discuss coverage of KidneyIntelX and kidneyintelX.dkd.
- Proposed LCDs published February 8, 2024; 45-day public comment period ends March 23, 2024.
- If covered, an estimated additional 5 million Medicare patients with Type 2 diabetes and early-stage CKD could gain access.
- New private payer contract with Velocity National Provider Network, covering 2.7 million member lives, effective January 2024.
- Final LCD expected during calendar year 2024 after public comment review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024004821/0000950170-24-004821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024004821/rnlx-20240117.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-004821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer